The Funded: One Bay Area SPAC merger died as another headed to a vote
In more signs of trouble in the blank-check merger market, Blade Therapeutics cancelled its planned deal. Meanwhile another startup is preparing for a shareholder vote after offering a disappointing financial forecast.